Argus upgraded Intl Flavors from Hold to Buy
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/7/2025 | Hold → Buy | Argus | |
| 11/12/2024 | $111.00 → $110.00 | Equal-Weight → Overweight | Morgan Stanley |
| 11/8/2024 | $107.00 | Neutral → Buy | BofA Securities |
| 11/7/2024 | $109.00 | Hold → Buy | Vertical Research |
| 9/11/2024 | $116.00 → $117.00 | Outperform | Oppenheimer |
| 9/3/2024 | $109.00 → $120.00 | Neutral → Outperform | Mizuho |
| 7/22/2024 | $95.00 → $115.00 | Hold → Buy | Stifel |
| 6/7/2024 | $116.00 | Outperform | Oppenheimer |
Argus upgraded Intl Flavors from Hold to Buy
Morgan Stanley upgraded Intl Flavors from Equal-Weight to Overweight and set a new price target of $110.00 from $111.00 previously
BofA Securities upgraded Intl Flavors from Neutral to Buy and set a new price target of $107.00
SC 13G/A - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Subject)
SC 13G/A - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Subject)
SC 13G - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Subject)
Alexandra Carlin and Alex Lee join the Paris-based fine fragrance team, bringing fresh artistic perspectives PARIS, Nov. 4, 2024 /PRNewswire/ -- IFF (NYSE:IFF) proudly welcomes Alexandra Carlin as Senior Fine Fragrance Perfumer and Alex Lee as Fine Fragrance Perfumer to its Paris-based team. These strategic additions aim to enhance the Company's creative prowess in the world of perfumery. "We're excited for the talent and creative energy that Alexandra and Alex will bring to IFF Scent," said Sabrya Meflah, president, Fine Fragrance, IFF. "Alexandra's ability to translate deep
NEW YORK, Sept. 26, 2024 /PRNewswire/ -- IFF (NYSE:IFF) Pharma Solutions is proud to announce its more than 75-year legacy as an excipient manufacturer with new product launches and technologies for the pharmaceutical and biotech industries. Celebrating this pivotal milestone, IFF will spotlight its latest solutions for nitrosamine mitigation at CPHI 2024, Milan, Oct. 8-10, booth 6B10. The range includes a new portfolio of low nitrite excipients and ultrapure alginate biopolymers for next-generation therapeutic development. "We are unveiling groundbreaking technologies that re
IFF (NYSE:IFF) today announced the appointment of Margarita Paláu-Hernández to its Board of Directors, effective June 3, 2024. Paláu-Hernández joins as a mutually agreed independent Director in connection with IFF's previously disclosed cooperation agreement with Icahn Capital LP and its affiliates. Following the appointment of Paláu-Hernández, the Board will be comprised of 11 members, ten of which are independent. "We are pleased to welcome Maggie to the IFF Board," said Roger Ferguson, lead director of IFF. "Her legal expertise, consumer insights, and her experience in emerging markets will be invaluable to IFF as we continue to execute on our growth and transformation plan to drive in
4 - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Issuer)
4 - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Issuer)
3 - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Issuer)
8-K - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Filer)
8-K - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Filer)
144 - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Subject)
Formulated for waterline application, Enviva® DUO supports gut integrity and ensures uniform product delivery to flocks, without settling in lines. NEW YORK, Jan. 15, 2025 /PRNewswire/ -- IFF (NYSE:IFF) today announced the launch of Enviva® DUO, a state-of-the-art direct-fed microbial (DFM) solution for poultry production. This innovative blend of two non-spore forming bacterial strains is designed to support the growth of beneficial gut bacteria during challenging conditions and encourage a favorable nutribiotic state ─ the interaction between nutrition, microbiome, and gut and immune function ─ for optimal bird performance.
Recognized for brand leadership with its "Timing is Everything" controlled release platform for oral drug delivery. NEW YORK, Jan. 14, 2025 /PRNewswire/ -- IFF (NYSE:IFF) Pharma Solutions, a global leader in polymer innovations, announced today that it has won the 2024 Pharmaceutical Technology Excellence Awards' Brand Leadership category for its "Timing is Everything" campaign. The campaign features IFF's newly designed controlled release platform, which provides customers with solutions at every turn. This award recognizes "Timing is Everything" campaign for its strategic ma
New initiative leverages AI and cultural insights to create unique fragrances for Chinese consumers, enhancing brand success. PARIS, Jan. 8, 2025 /PRNewswire/ -- IFF (NYSE:IFF) today launched its China Scent Exploration Program, a comprehensive consumer learning initiative designed to create fragrances specifically for the Chinese region. This program builds on IFF's deep regional expertise, which began in 1981 when it became the first multinational fragrance company to establish operations in China. "The Chinese fragrance market represents one of our industry's most exciting opportunities," said Ana Paula Mendonça, president, Scent, IFF. "By combining artificial intelligence with deep cult
IFF (NYSE:IFF) reported financial results for the third quarter ended September 30, 2024. Third Quarter 2024 Consolidated Summary: Reported (GAAP) Adjusted (Non-GAAP)1 Sales Income Before Taxes EPS Operating EBITDA Operating EBITDA Margin EPS ex Amortization $2.9 B $95 M $0.23 $568 M 19.4% $1.04 First Nine Months 2024 Consolidated Summary: Reported (GAAP) Adjusted (Non-GAAP)1 Sales Income Before Taxes EPS Operating EBITDA Operating EBITDA Margin EPS ex Amortization $8.7 B $393 M
IFF (NYSE:IFF) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.40 per share of its common stock, payable on January 8, 2025 to shareholders of record as of December 20, 2024. Welcome to IFF At IFF (NYSE:IFF), an industry leader in food, beverage, scent, health and biosciences, science and creativity meet to create essential solutions for a better world – from global icons to unexpected innovations and experiences. With the beauty of art and the precision of science, we are an international collective of thinkers who partners with customers to bring scents, tastes, experiences, ingredients and solutions for products the world craves. Together, we
IFF (NYSE:IFF) today announced that it will release its third quarter 2024 earnings results following the market close on Tuesday, Nov. 5, 2024. The management team will host a live webcast on Wednesday, Nov. 6, 2024 at 9:00 a.m. ET to discuss results and outlook with the investor community. Investors may access the live webcast and accompanying slide presentation on the Company's website at ir.iff.com. For those unable to listen to the live webcast, a recorded version will be made available for replay. Welcome to IFF At IFF (NYSE:IFF), an industry leader in food, beverage, health, biosciences and scent, science and creativity meet to create essential solutions for a better world – from g